secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocugen, Inc. (OCGN)
CIK:        0001372299
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0001628280-25-021359
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocugen presents clinical trial data at Eyecelerator conference
--------------------------------------------------------------

- Presentation furnished as Exhibit 99.1; used at May 2, 2025 Eyecelerator showcase.
- Data shows mean change in BCVA and visual field responder proportions.
- Specific numerical results not fully extractable due to formatting in filing text.
- No new financial results, guidance, or corporate updates provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372299/000162828025021359/0001628280-25-021359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372299/000162828025021359/ocgn-20250501.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-021359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer